134 related articles for article (PubMed ID: 31288958)
1. Laboratory Evaluation of Spasmodic Dysphonia.
Othman S; Daggumati S; Patel R; Ross J; Sataloff RT
J Voice; 2020 Nov; 34(6):934-939. PubMed ID: 31288958
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Evaluation of Vocal Fold Paralysis and Paresis.
White M; Meenan K; Patel T; Jaworek A; Sataloff RT
J Voice; 2017 Mar; 31(2):168-174. PubMed ID: 27777055
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
Dewan K; Berke GS
J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
[TBL] [Abstract][Full Text] [Related]
4. Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology.
Hintze JM; Ludlow CL; Bansberg SF; Adler CH; Lott DG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):558-564. PubMed ID: 28850796
[TBL] [Abstract][Full Text] [Related]
5. Pharyngeal Dystonia Mimicking Spasmodic Dysphonia.
Shi LL; Simpson CB; Hapner ER; Jinnah HA; Johns MM
J Voice; 2018 Mar; 32(2):234-238. PubMed ID: 28651822
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.
Lerner MZ; Lerner BA; Patel AA; Blitzer A
Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917
[TBL] [Abstract][Full Text] [Related]
7. Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia.
Karatayli Ozgursoy S; Vargas ER; Heckman MG; Rutt AL
Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):198-203. PubMed ID: 32773781
[TBL] [Abstract][Full Text] [Related]
8. The effect of unilateral thalamic deep brain stimulation on the vocal dysfunction in a patient with spasmodic dysphonia: interrogating cerebellar and pallidal neural circuits.
Poologaindran A; Ivanishvili Z; Morrison MD; Rammage LA; Sandhu MK; Polyhronopoulos NE; Honey CR
J Neurosurg; 2018 Feb; 128(2):575-582. PubMed ID: 28304188
[TBL] [Abstract][Full Text] [Related]
9. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).
Stachler RJ; Francis DO; Schwartz SR; Damask CC; Digoy GP; Krouse HJ; McCoy SJ; Ouellette DR; Patel RR; Reavis CCW; Smith LJ; Smith M; Strode SW; Woo P; Nnacheta LC
Otolaryngol Head Neck Surg; 2018 Mar; 158(1_suppl):S1-S42. PubMed ID: 29494321
[TBL] [Abstract][Full Text] [Related]
11. Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors.
Hintze JM; Ludlow CL; Bansberg SF; Adler CH; Lott DG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):551-557. PubMed ID: 28850801
[TBL] [Abstract][Full Text] [Related]
12. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
[TBL] [Abstract][Full Text] [Related]
13. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
Chen W; Woo P; Murry T
J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
[TBL] [Abstract][Full Text] [Related]
14. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
15. The Reflux Symptom Index and Symptom Overlap in Dysphonic Patients.
Kavookjian H; Irwin T; Garnett JD; Kraft S
Laryngoscope; 2020 Nov; 130(11):2631-2636. PubMed ID: 32027383
[TBL] [Abstract][Full Text] [Related]
16. The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients.
Patel AB; Bansberg SF; Adler CH; Lott DG; Crujido L
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):859-63. PubMed ID: 26024910
[TBL] [Abstract][Full Text] [Related]
17. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
18. Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population.
Nerurkar NK; Banu TP
J Laryngol Otol; 2014 Jul; 128(7):649-53. PubMed ID: 24999662
[TBL] [Abstract][Full Text] [Related]
19. Otolaryngeal and Oropharyngeal Conditions: Dysphonia.
Gauer RL
FP Essent; 2021 Feb; 501():11-16. PubMed ID: 33595263
[TBL] [Abstract][Full Text] [Related]
20. Voice analysis in adductor spasmodic dysphonia: Objective diagnosis and response to botulinum toxin.
Suppa A; Asci F; Saggio G; Marsili L; Casali D; Zarezadeh Z; Ruoppolo G; Berardelli A; Costantini G
Parkinsonism Relat Disord; 2020 Apr; 73():23-30. PubMed ID: 32222482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
